Have a personal or library account? Click to login
Dithiothreitol treatment of red blood cells Cover

Dithiothreitol treatment of red blood cells

By: C.B. Bub  
Paid access
|Oct 2019

References

  1. Fung MK, Grossman BJ, Hillyer CD, Westhoff CM. Technical manual. 19th ed. Bethesda, MD: American Association of Blood Banks, 2017: Method 3–18.
  2. Branch DR, Muensch HA, Sy Siok Hian S, Petz LD. Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Br J Haematol 1983;54:573–8.10.1111/j.1365-2141.1983.tb02136.x6871108
  3. Reid ME, Lomas-Francis C, Olsson M. The blood group antigen factsbook. 3rd ed. London:Elsevier Academic Press, 2012.10.1016/B978-0-12-415849-8.00026-0
  4. Fung MK, Grossman BJ, Hillyer CD, Westhoff CM. Eds. Technical manual. 19th ed. Bethesda, MD: American Association of Blood Banks, 2017: Method 2–18.
  5. Murphy MF, Dumont LJ, Greinacher A. Interference of new drugs with compatibility testing for blood transfusion. N Engl J Med 2016;375:295–6.10.1056/NEJMc151596927468082
  6. Chapuy CI, Aguad MD, Nicholson RT, Aubuchon JP, Cohn CS, Delaney M, et al. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing. Transfusion 2016;56:2964–72.10.1111/trf.1378927600566
  7. Disbro WL. Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab. Immunohematology 2017;33:105–9.10.21307/immunohematology-2019-015
DOI: https://doi.org/10.21307/immunohematology-2019-025 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 170 - 172
Published on: Oct 16, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 C.B. Bub, published by American National Red Cross
This work is licensed under the Creative Commons License.